Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Surgery 1.4.3 Targeted Drugs Therapy 1.4.4 Chemo Therapy 1.4.5 Adjuvant Chemotherapy 1.4.6 Radiation Therapy 1.5 Market by Application 1.5.1 Global Gastrointestinal Cancer Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Research Centers 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Gastrointestinal Cancer Treatment Market Perspective (2015-2026) 2.2 Gastrointestinal Cancer Treatment Growth Trends by Regions 2.2.1 Gastrointestinal Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Gastrointestinal Cancer Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Gastrointestinal Cancer Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Gastrointestinal Cancer Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Gastrointestinal Cancer Treatment Players by Market Size 3.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2015-2020) 3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gastrointestinal Cancer Treatment Market Concentration Ratio 3.2.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2019 3.3 Gastrointestinal Cancer Treatment Key Players Head office and Area Served 3.4 Key Players Gastrointestinal Cancer Treatment Product Solution and Service 3.5 Date of Enter into Gastrointestinal Cancer Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2015-2020) 4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2021-2026) 5 Gastrointestinal Cancer Treatment Breakdown Data by Application (2015-2026) 5.1 Global Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Gastrointestinal Cancer Treatment Market Size (2015-2020) 6.2 Gastrointestinal Cancer Treatment Key Players in North America (2019-2020) 6.3 North America Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 6.4 North America Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Gastrointestinal Cancer Treatment Market Size (2015-2020) 7.2 Gastrointestinal Cancer Treatment Key Players in Europe (2019-2020) 7.3 Europe Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 7.4 Europe Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 8 China 8.1 China Gastrointestinal Cancer Treatment Market Size (2015-2020) 8.2 Gastrointestinal Cancer Treatment Key Players in China (2019-2020) 8.3 China Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 8.4 China Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Gastrointestinal Cancer Treatment Market Size (2015-2020) 9.2 Gastrointestinal Cancer Treatment Key Players in Japan (2019-2020) 9.3 Japan Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 9.4 Japan Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Gastrointestinal Cancer Treatment Market Size (2015-2020) 10.2 Gastrointestinal Cancer Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 11 India 11.1 India Gastrointestinal Cancer Treatment Market Size (2015-2020) 11.2 Gastrointestinal Cancer Treatment Key Players in India (2019-2020) 11.3 India Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 11.4 India Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Gastrointestinal Cancer Treatment Market Size (2015-2020) 12.2 Gastrointestinal Cancer Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) 12.4 Central & South America Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Eli Lilly 13.1.1 Eli Lilly Company Details 13.1.2 Eli Lilly Business Overview and Its Total Revenue 13.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction 13.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2015-2020)) 13.1.5 Eli Lilly Recent Development 13.2 F. Hoffmann 13.2.1 F. Hoffmann Company Details 13.2.2 F. Hoffmann Business Overview and Its Total Revenue 13.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction 13.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.2.5 F. Hoffmann Recent Development 13.3 GlaxoSmithKline 13.3.1 GlaxoSmithKline Company Details 13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction 13.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.3.5 GlaxoSmithKline Recent Development 13.4 Merck 13.4.1 Merck Company Details 13.4.2 Merck Business Overview and Its Total Revenue 13.4.3 Merck Gastrointestinal Cancer Treatment Introduction 13.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.4.5 Merck Recent Development 13.5 Novartis AG 13.5.1 Novartis AG Company Details 13.5.2 Novartis AG Business Overview and Its Total Revenue 13.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction 13.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.5.5 Novartis AG Recent Development 13.6 Otsuka Holdings 13.6.1 Otsuka Holdings Company Details 13.6.2 Otsuka Holdings Business Overview and Its Total Revenue 13.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction 13.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.6.5 Otsuka Holdings Recent Development 13.7 Stryker Corporation 13.7.1 Stryker Corporation Company Details 13.7.2 Stryker Corporation Business Overview and Its Total Revenue 13.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction 13.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.7.5 Stryker Corporation Recent Development 13.8 Boston Scientific Corporation 13.8.1 Boston Scientific Corporation Company Details 13.8.2 Boston Scientific Corporation Business Overview and Its Total Revenue 13.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction 13.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.8.5 Boston Scientific Corporation Recent Development 13.9 Johnson and Johnson 13.9.1 Johnson and Johnson Company Details 13.9.2 Johnson and Johnson Business Overview and Its Total Revenue 13.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction 13.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.9.5 Johnson and Johnson Recent Development 13.10 CONMED Corporation 13.10.1 CONMED Corporation Company Details 13.10.2 CONMED Corporation Business Overview and Its Total Revenue 13.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction 13.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) 13.10.5 CONMED Corporation Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Gastrointestinal Cancer Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue Table 3. Ranking of Global Top Gastrointestinal Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Surgery Table 6. Key Players of Targeted Drugs Therapy Table 7. Key Players of Chemo Therapy Table 8. Key Players of Adjuvant Chemotherapy Table 9. Key Players of Radiation Therapy Table 10. Global Gastrointestinal Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Gastrointestinal Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Gastrointestinal Cancer Treatment Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Gastrointestinal Cancer Treatment Market Share by Regions (2015-2020) Table 14. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Gastrointestinal Cancer Treatment Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Gastrointestinal Cancer Treatment Market Growth Strategy Table 20. Main Points Interviewed from Key Gastrointestinal Cancer Treatment Players Table 21. Global Gastrointestinal Cancer Treatment Revenue by Players (2015-2020) (Million US$) Table 22. Global Gastrointestinal Cancer Treatment Market Share by Players (2015-2020) Table 23. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Cancer Treatment as of 2019) Table 24. Global Gastrointestinal Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Gastrointestinal Cancer Treatment Product Solution and Service Table 27. Date of Enter into Gastrointestinal Cancer Treatment Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 30. Global Gastrointestinal Cancer Treatment Market Size Share by Type (2015-2020) Table 31. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Gastrointestinal Cancer Treatment Market Size Share by Application (2015-2020) Table 33. Global Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 34. Global Gastrointestinal Cancer Treatment Market Size Share by Application (2021-2026) Table 35. North America Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 36. North America Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 37. North America Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 38. North America Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 39. North America Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 40. North America Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 41. Europe Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 43. Europe Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 44. Europe Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 45. Europe Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 46. Europe Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 47. China Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 48. China Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 49. China Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 50. China Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 51. China Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 52. China Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 53. Japan Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 55. Japan Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 56. Japan Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 57. Japan Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 58. Japan Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 61. Southeast Asia Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 63. Southeast Asia Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 65. India Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 66. India Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 67. India Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 68. India Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 69. India Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 70. India Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 71. Central & South America Key Players Gastrointestinal Cancer Treatment Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Gastrointestinal Cancer Treatment Market Share (2019-2020) Table 73. Central & South America Gastrointestinal Cancer Treatment Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Gastrointestinal Cancer Treatment Market Share by Type (2015-2020) Table 75. Central & South America Gastrointestinal Cancer Treatment Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Gastrointestinal Cancer Treatment Market Share by Application (2015-2020) Table 77. Eli Lilly Company Details Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Product Table 80. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 81. Eli Lilly Recent Development Table 82. F. Hoffmann Company Details Table 83. F. Hoffmann Business Overview Table 84. F. Hoffmann Product Table 85. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 86. F. Hoffmann Recent Development Table 87. GlaxoSmithKline Company Details Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Product Table 90. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 91. GlaxoSmithKline Recent Development Table 92. Merck Company Details Table 93. Merck Business Overview Table 94. Merck Product Table 95. Merck Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 96. Merck Recent Development Table 97. Novartis AG Company Details Table 98. Novartis AG Business Overview Table 99. Novartis AG Product Table 100. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 101. Novartis AG Recent Development Table 102. Otsuka Holdings Company Details Table 103. Otsuka Holdings Business Overview Table 104. Otsuka Holdings Product Table 105. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 106. Otsuka Holdings Recent Development Table 107. Stryker Corporation Company Details Table 108. Stryker Corporation Business Overview Table 109. Stryker Corporation Product Table 110. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 111. Stryker Corporation Recent Development Table 112. Boston Scientific Corporation Business Overview Table 113. Boston Scientific Corporation Product Table 114. Boston Scientific Corporation Company Details Table 115. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 116. Boston Scientific Corporation Recent Development Table 117. Johnson and Johnson Company Details Table 118. Johnson and Johnson Business Overview Table 119. Johnson and Johnson Product Table 120. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 121. Johnson and Johnson Recent Development Table 122. CONMED Corporation Company Details Table 123. CONMED Corporation Business Overview Table 124. CONMED Corporation Product Table 125. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2015-2020) (Million US$) Table 126. CONMED Corporation Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Gastrointestinal Cancer Treatment Market Share by Type: 2020 VS 2026 Figure 2. Surgery Features Figure 3. Targeted Drugs Therapy Features Figure 4. Chemo Therapy Features Figure 5. Adjuvant Chemotherapy Features Figure 6. Radiation Therapy Features Figure 7. Global Gastrointestinal Cancer Treatment Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Research Centers Case Studies Figure 11. Others Case Studies Figure 12. Gastrointestinal Cancer Treatment Report Years Considered Figure 13. Global Gastrointestinal Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Gastrointestinal Cancer Treatment Market Share by Regions: 2020 VS 2026 Figure 15. Global Gastrointestinal Cancer Treatment Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Gastrointestinal Cancer Treatment Market Share by Players in 2019 Figure 18. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Cancer Treatment as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2019 Figure 20. North America Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. China Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Japan Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Southeast Asia Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. India Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Central & South America Gastrointestinal Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 29. F. Hoffmann Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 31. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 35. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 37. Otsuka Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 39. Stryker Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 41. Boston Scientific Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 43. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 45. CONMED Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2015-2020) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Eli Lilly F. Hoffmann GlaxoSmithKline Merck Novartis AG Otsuka Holdings Stryker Corporation Boston Scientific Corporation Johnson and Johnson CONMED Corporation